Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
12.79
+0.33 (2.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
DAWN Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 422.77 | 230.78 | 85.26 | 284.31 | 43.73 | 27.33 |
Short-Term Investments | 135.62 | 135.56 | 257.01 | - | - | - |
Cash & Short-Term Investments | 558.38 | 366.35 | 342.27 | 284.31 | 43.73 | 27.33 |
Cash Growth | 37.69% | 7.03% | 20.39% | 550.18% | 59.99% | - |
Prepaid Expenses | 4.8 | 3.27 | 2.6 | 2.96 | 0.08 | 0.01 |
Other Current Assets | 6.38 | 5.66 | 3.01 | 2.1 | 1.26 | - |
Total Current Assets | 581 | 375.27 | 347.87 | 289.37 | 45.07 | 27.34 |
Property, Plant & Equipment | 3.48 | 0.56 | 0.72 | 0.28 | 0.48 | - |
Long-Term Deferred Charges | - | - | - | - | 0.04 | - |
Other Long-Term Assets | 0.12 | 0.21 | 0.47 | 0.17 | 0.07 | - |
Total Assets | 600.81 | 376.05 | 349.06 | 289.82 | 45.66 | 27.34 |
Accounts Payable | 3.02 | 2.58 | 0.26 | 1.74 | 0.2 | 0.07 |
Accrued Expenses | 30.69 | 25.48 | 15.77 | 6.61 | 1.57 | 0.47 |
Current Portion of Leases | 0.08 | 0.41 | 0.41 | 0.2 | 0.2 | - |
Other Current Liabilities | 4.5 | 1.04 | 0.18 | 0.1 | 0.03 | 1.49 |
Total Current Liabilities | 39.75 | 29.51 | 16.62 | 8.66 | 2 | 2.02 |
Long-Term Leases | 2.54 | - | 0.41 | 0.02 | 0.2 | - |
Total Liabilities | 45.34 | 29.51 | 17.02 | 8.67 | 2.2 | 2.02 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 2 | 2 |
Additional Paid-In Capital | 1,044 | 805.11 | 601.77 | 408.63 | - | - |
Retained Earnings | -488.37 | -458.59 | -269.67 | -127.49 | -56.84 | -12.78 |
Comprehensive Income & Other | -0.01 | 0.01 | -0.07 | - | 0.64 | 0.11 |
Total Common Equity | 555.46 | 346.54 | 332.04 | 281.15 | -54.21 | -10.67 |
Minority Interest | - | - | - | - | 5.7 | 5.49 |
Shareholders' Equity | 555.46 | 346.54 | 332.04 | 281.15 | 43.46 | 25.32 |
Total Liabilities & Equity | 600.81 | 376.05 | 349.06 | 289.82 | 45.66 | 27.34 |
Total Debt | 2.62 | 0.41 | 0.81 | 0.22 | 0.4 | - |
Net Cash (Debt) | 555.77 | 365.94 | 341.46 | 284.09 | 43.33 | 27.33 |
Net Cash Growth | 37.22% | 7.17% | 20.19% | 555.70% | 58.52% | - |
Net Cash Per Share | 6.24 | 4.59 | 5.22 | 7.69 | 7.84 | 4.61 |
Filing Date Shares Outstanding | 100.85 | 87.38 | 73.59 | 61.95 | 2.6 | 5.92 |
Total Common Shares Outstanding | 100.81 | 87.23 | 73.46 | 61.95 | 2.6 | 5.92 |
Working Capital | 541.25 | 345.77 | 331.26 | 280.71 | 43.08 | 25.32 |
Book Value Per Share | 5.51 | 3.97 | 4.52 | 4.54 | -20.88 | -4.19 |
Tangible Book Value | 539.25 | 346.54 | 332.04 | 281.15 | -54.21 | -10.67 |
Tangible Book Value Per Share | 5.35 | 3.97 | 4.52 | 4.54 | -20.88 | -4.19 |
Machinery | - | - | - | 0.08 | 0.08 | - |
Leasehold Improvements | - | - | - | 0.02 | 0.02 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.